Search
forResearch 10 of 57
- Evaluating safety and ethical implications of androgenetic alopecia treatments: a comparison of direct-to-consumer platforms and dermatologist visits
- Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
- Direct-to-consumer teledermatology’s limitations may be addressed with greater in-person care synergy
- Discount pharmacies may save patients significant money on androgenetic alopecia medications compared to both traditional pharmacies and direct-to-consumer companies
- Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study
- Accessibility of direct-to-consumer teledermatology to underserved populations
- Direct-to-Consumer Teledermatology for Male Androgenetic Alopecia: Narrative Review
- Direct-to-Consumer Teledermatology Growth: A Review and Outlook for the Future
- Direct-to-consumer commercial virtual care: a scoping review
- Direct‐to‐consumer healthcare and its expanding role in the Australian healthcare system
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →